Literature DB >> 31734104

Cenobamate: new hope for treatment-resistant epilepsy.

Stephan Arnold1.   

Abstract

Entities:  

Year:  2019        PMID： 31734104     DOI： 10.1016/S1474-4422(19)30434-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  2 in total

Review 1.  [Cenobamate-a new perspective for epilepsy treatment].

Authors:  Bernhard J Steinhoff
Journal:  Nervenarzt       Date:  2020-09-29       Impact factor: 1.214

2.  Inhibition of p38 MAPK regulates epileptic severity by decreasing expression levels of A1R and ENT1.

Authors:  Xuejiao Zhou; Qian Chen; Hao Huang; Jun Zhang; Jing Wang; Ya Chen; Yan Peng; Haiqing Zhang; Junwei Zeng; Zhanhui Feng; Zucai Xu
Journal:  Mol Med Rep       Date:  2020-10-19       Impact factor: 2.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.